Cite Filings / XFOR / 0001193125-26-226568

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

X4 Pharmaceuticals, Inc Filed 2026-05-15 Acc 0001193125-26-226568

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-14 EFFECT Notice of Effectiveness
2026-05-13 8-K/A Executive or director change · Shareholder vote results
2026-05-13 4 Chief Financial Officer sold 16,961 shares at $4.29 ($72,820)
2026-05-12 144 Sale of Securities
2026-03-06 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…